BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 22823452)

  • 21. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
    Sengupta S; Weerakoon M; Sethi K; Ischia J; Webb DR
    BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes].
    Winter A; Vogt C; Weckermann D; Wawroschek F
    Aktuelle Urol; 2011 May; 42(3):179-83. PubMed ID: 21409742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer.
    Mandel P; Kriegmair MC; Veleva V; Salomon G; Graefen M; Huland H; Tilki D
    Urology; 2016 Jul; 93():141-6. PubMed ID: 26968487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.
    Morizane S; Honda M; Fukasawa S; Komaru A; Inokuchi J; Eto M; Shimbo M; Hattori K; Kawano Y; Takenaka A
    Int J Clin Oncol; 2018 Jun; 23(3):568-575. PubMed ID: 29230586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
    Canda AE; Atmaca AF; Altinova S; Akbulut Z; Balbay MD
    BJU Int; 2012 Aug; 110(3):434-44. PubMed ID: 22177416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?
    Touijer K; Fuenzalida RP; Rabbani F; Paparel P; Nogueira L; Cronin AM; Fine SW; Guillonneau B
    BJU Int; 2011 Aug; 108(3):372-7. PubMed ID: 21199284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of extraperitoneal and transperitoneal pelvic lymph node dissection during minimally invasive radical prostatectomy.
    Mullins JK; Hyndman ME; Mettee LZ; Pavlovich CP
    J Endourol; 2011 Dec; 25(12):1883-7. PubMed ID: 21749195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
    Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
    Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.
    Kazzazi A; Djavan B
    Can J Urol; 2011 Apr; 18(2):5585-91. PubMed ID: 21504645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille.
    Maderthaner L; Furrer MA; Studer UE; Burkhard FC; Thalmann GN; Nguyen DP
    BJU Int; 2018 May; 121(5):725-731. PubMed ID: 28834085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
    Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
    Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
    Eden CG; Arora A; Rouse P
    BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.
    Modi PK; Bock M; Kim S; Singer EA; Parikh RR
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1001-e1006. PubMed ID: 28558990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
    Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
    Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.
    Gandaglia G; Suardi N; Gallina A; Abdollah F; Capitanio U; Salonia A; Colombo R; Bianchi M; Chun FK; Hansen J; Rigatti P; Montorsi F; Briganti A
    J Sex Med; 2012 Aug; 9(8):2187-94. PubMed ID: 22738395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.